For some people, functional foods may play a role in managing their risk of chronic disease, such as the metabolic syndrome (see notes below). However, for the potential of these foods to be maximised, they need to be acceptable to consumers and consumed on a regular basis. Research to assess consumers’ views of functional foods, along with consumers’ attitudes to the use of new agro-food technologies and genetically modified foods, has been undertaken with consumers from 6 EU countries.
Preliminary findings indicate that generally people are happy to purchase functional foods because they feel that they have health benefiting properties; and although consumers had reservations about foods that had been genetically modified, if they felt that such foods could help tackle chronic health conditions, they felt that they would be a good option.
This work is part of the €12.5m project entitled Lipgene, funded by the EU, which also includes research assessing the potential of modern agro-food technologies to change the fatty acid profile of foods. For example, investigations are underway into the extent to which improvements in the fatty acid profile of milk and meat can be made through changes in the animal’s diet. Also, using genetic engineering technology, researchers are exploring the possibility of developing a rapeseed oil that contains long chain omega 3 polyunsaturates, found to be beneficial for heart health. Lipgene is also investigating the effects of diets with modified fat content on an individual’s risk and management of the metabolic syndrome, taking account of how genetic variation may modify these effects.
In the future it may be possible to tailor our diets based on our genotype to minimise the risk of developing certain diseases, such as the metabolic syndrome. Such cutting edge developments have the potential to make a great difference to consumers’ health as part of a healthy diet; yet, will have little impact if they are not fully understood or accepted. The conference in London will be the first opportunity to discuss the enlightening findings from this consumer research.
Georgina Bentley | alfa
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
20.03.2018 | Agricultural and Forestry Science
20.03.2018 | Life Sciences
20.03.2018 | Life Sciences